LENSAR (NASDAQ:LNSR – Get Free Report) will announce its earnings results before the market opens on Thursday, May 9th. Parties interested in listening to the company’s conference call can do so using this link.
LENSAR (NASDAQ:LNSR – Get Free Report) last released its earnings results on Monday, March 4th. The company reported ($0.22) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.22). LENSAR had a negative return on equity of 40.53% and a negative net margin of 34.11%. The firm had revenue of $12.11 million for the quarter.
LENSAR Trading Up 1.6 %
Shares of NASDAQ LNSR opened at $3.26 on Wednesday. LENSAR has a twelve month low of $1.80 and a twelve month high of $5.30. The firm has a 50-day moving average of $3.62 and a two-hundred day moving average of $3.33. The company has a market capitalization of $37.16 million, a price-to-earnings ratio of -1.82 and a beta of 0.49.
Analyst Ratings Changes
View Our Latest Report on LNSR
About LENSAR
LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.
See Also
- Five stocks we like better than LENSAR
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Garmin Navigates to New Highs Driven By Wearables Trend
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- Retail Stocks Investing, Explained
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for LENSAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LENSAR and related companies with MarketBeat.com's FREE daily email newsletter.